This webinar marks the sixth installment in a series dedicated to delving into the groundbreaking innovations outlined in the 2022 ESC/ERS clinical guidelines for the diagnosis and treatment of pulmonary hypertension. One particularly notable advancement is the inclusion of a new section focusing onย โPatient Associations and Patient Empowerment.โ Additionally, the guidelines now recommend that pulmonary hypertension centers establish collaborative partnerships with patient associations.ย The program for this series was established in close collaboration with Prof. Marc Humbert, Director of the French National Reference Center for Pulmonary Hypertension, and a global authority in the field.
Link to join:ย https://us06web.zoom.us/j/84739436854?pwd=qy7f0E2iDCyQVVSobI4XQPHshdEJTN.1
Meeting IDย 847 3943 6854
Passcodeย 842936
Speakersย (alphabetical order)
- Pisana Ferrari โ Secretary General, Alliance for Pulmonary Hypertension and President of AIPI, Italian Pulmonary Hypertension Association
- Mรฉlanie Gallant Dewavrin, Director of HTaPFrance, French pulmonary hypertension association
- Matt Granato โ President and CEO of the PHA, Pulmonary Hypertension Association
- Dieter Kulla โ President of ph e.v., German pulmonary hypertension patient association
- Gergely Meszaros, Project Manager at ERN-LUNG
Learning objectives
This webinar aims to provide a historical overview of the pulmonary hypertension association โmovementโ and its evolution over the past three decades. We will explore its journey and highlight its current pivotal role in pulmonary hypertension care. Understanding this evolution is key to recognizing the substantial impact patient associations have had on shaping todayโs PH care landscape.
Agenda of webinar
- Introduction โ Pisana Ferrari
- The โPioneersโ: the first world pulmonary hypertension associations
- The PHA โย Matt Granato
- HTaPFrance โย Mรฉlanie Gallant-Dewavrin
- pulmonale hypertonie e.v. โย Hans-Dieter Kulla
- The Current Landscape: A 30-Year Overview of World PH Associations and Umbrella Organizations โ Pisana Ferrari
- Evolution of the Role of Patient Associations and challenges for their future โ Gergely Meszaros
- Q&A Session